Somatostatin and neuropeptide Y are unaltered in the amygdala in schizophrenia
Although a biochemical abnormality has been postulated in the etiology of schizophrenia, evidence supporting this hypothesis has been conflicting. Because of the presence of somatostatin-like immunoreactivity (SLI) in limbic system nuclei of the brain, we examined postmortem concentrations of SLI in patients dying with schizophrenia and in normal controls. Concentrations of SLI in Brodmann cortical area 38, hippocampus, caudate, putamen, nucleus accumbens, and both segments of the globus pallidus were not significantly different from controls. In addition, we examined both SLI and neuropeptide-Y-like immunoreactivity (NPYLI) in subnuclei of the amygdala and the substantia innominata. There were no significant alterations in either neuropeptide as compared with controls.
Index EntriesSomatostatin neuropeptide Y amygdala schizophrenia
Unable to display preview. Download preview PDF.
- Arnold M. A., Reppert S. M., Rorstad O. P., Sagar S. M., Keutmann H. T., Perlow M. J., and Martin J. B. (1982) Temporal patterns of somatostatin immunoreactivity in the cerebrospinal fluid of the rhesus monkey: Effect of environmental lighting.J. Neurosci. 2, 574–580.Google Scholar
- Beal M. F., Mazurek M. F., and Martin J. B. (1986c) A comparison of somatostatin and neuropeptide Y distribution in monkey brain.Brain Res., in press.Google Scholar
- Feighner J. P., Robins E., Guzes S. P., Woodruff R. A., Winokur E., and Munoz R. J. (1972) Diagnostic criteria for use in psychiatric research.Arch. Gen. Psych. 26, 57–63.Google Scholar
- Ferrier I. W., Roberts G. W., Crow T. J., Johnstone E. C., Owens D. G. C., Lee Y. C., O'Shaughenssey D., Adrian T. E., Polak J. M., and Bloom S. R. (1983) Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia.Life Sci. 33, 475–482.PubMedCrossRefGoogle Scholar
- Hokfelt T., Lundberg J. M., Lagercrantz H., Tatemoto K., Mutt V., Lindberg J., Terenius L., Everitt B. J., Fuxe K., Agnati L., and Goldstein M. (1983) Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata.Neurosci. Lett. 36, 217–222.PubMedCrossRefGoogle Scholar
- Kety S. S., Rosenthal D., Wender P. H., Schulsinger F., and Jacobsen B. (1975) Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic: A preliminary report based on psychiatric interviews, inGenetic Research in Psychiatry (Fieve R., Rosenthal R., and Brill H., eds.) pp. 147–165. Johns Hopkins, Baltimore, MD.Google Scholar
- Kluver H. and Bucy P. C. (1939) Preliminary analysis of functions of the temporal lobes in monkeys.Arch. Neurol. Psych. 42, 979–1000.Google Scholar
- Svendsen C. N., Langlais P. J., Benes F. M., and Bird E. D. (1986) Monoamine levels in the left and right amygdaloid complex of schizophrenic postmortem brain tissue, inBiological Psychiatry (Shagass C. et al., eds.) pp. 1115–1117, Elsevier, Amsterdam, Netherlands.Google Scholar